Human Albumin Csl Behring (Human Plasma Protein)

Human Albumin Csl Behring is employed clinically as a volume expander and protein replacement in several medical situations where plasma albumin levels are low or rapid fluid shifts occur.

• Management of hypovolemia due to acute blood loss or trauma.
• Treatment of hypoalbuminemia associated with liver cirrhosis or nephrotic syndrome.
• Support during major surgery or extensive burns to maintain oncotic pressure.
• Adjunct therapy in patients receiving parenteral nutrition with low serum albumin.
• Correction of dilutional coagulopathy in massive transfusion protocols.

• Human albumin increases plasma oncotic pressure by contributing to the colloid osmotic gradient within the vascular compartment. The infused protein binds water, drawing fluid from the interstitial space into the circulation, thereby expanding intravascular volume. This effect helps restore hemodynamic stability and supports tissue perfusion. Albumin also serves as a carrier for endogenous substances such as hormones, fatty acids, and drugs, influencing their distribution.

Adverse reactions to Human Albumin Csl Behring are generally infrequent but may range from mild to severe.

Common

• Transient fever or chills.
• Mild hypotension or hypertension.
• Headache or dizziness.

Serious

• Anaphylactic or severe allergic reaction.
• Pulmonary edema from volume overload.
• Acute respiratory distress syndrome (ARDS).

When prescribing Human Albumin Csl Behring, clinicians should evaluate patient-specific factors and monitor for potential complications.

• Assess volume status to avoid fluid overload.
• Use caution in patients with heart failure or renal insufficiency.
• Monitor serum albumin and electrolytes during therapy.
• Adjust dose in patients with severe hypoalbuminemia.
• Avoid rapid infusion rates; infuse over recommended time.
• Discontinue if signs of allergic reaction appear.

Human Albumin may interact with other agents that affect fluid balance, coagulation, or immune response.

Avoid

• Concomitant use of high‑dose diuretics that may exacerbate hypovolemia.
• Simultaneous administration of other volume expanders without careful monitoring.
• Use with agents that increase risk of pulmonary edema (e.g., excessive crystalloid fluids).

Use with caution

• Blood products or plasma derivatives that may increase oncotic load.
• Medications that bind albumin (e.g., warfarin, phenytoin) as they may alter drug levels.
• Immunosuppressive therapies that could mask allergic reactions.